Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)

v3.19.3.a.u2
Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 17,502 $ 4 $ 128,549,458 $ (169,180,425) $ (40,613,461)
Balance, shares at Dec. 31, 2017 1,750,275 39,502      
Common stock issued in cashless exercise of warrants $ 15 (15)
Common stock issued in cashless exercise of warrants, shares 151,200      
Conversion of debentures into common stock $ 67 3,056,607 3,056,674
Conversion of debentures into common stock, shares 666,621      
Stock-based compensation 24,196 24,196
Restricted stock issued to employees $ 14 641,096 641,110
Restricted stock issued to employees, shares 142,667      
Shares returned to treasury
Shares returned to treasury, shares (5)      
Beneficial conversion feature of preferred stock (651,562) (651,562)
Net income (loss) (146,364,582) (146,364,582)
Balance at Mar. 31, 2018 $ 17,502 $ 100 131,619,780 (315,545,007) (183,907,625)
Balance, shares at Mar. 31, 2018 1,750,275 999,985      
Balance at Dec. 31, 2017 $ 17,502 $ 4 128,549,458 (169,180,425) (40,613,461)
Balance, shares at Dec. 31, 2017 1,750,275 39,502      
Modification of warrants        
Net income (loss)         (3,850,011)
Balance at Sep. 30, 2018 $ 20,002 $ 737 160,817,543 (190,973,013) (30,134,731)
Balance, shares at Sep. 30, 2018 2,000,225 7,365,881      
Balance at Mar. 31, 2018 $ 17,502 $ 100 131,619,780 (315,545,007) (183,907,625)
Balance, shares at Mar. 31, 2018 1,750,275 999,985      
Common stock issued in cashless exercise of warrants $ 57 3,957,710 3,957,767
Common stock issued in cashless exercise of warrants, shares 572,480      
Conversion of debentures into common stock $ 157 4,036,932 4,037,089
Conversion of debentures into common stock, shares 1,571,000      
Stock-based compensation 24,197 24,197
Shares returned to treasury (28,217) (28,217)
Shares returned to treasury, shares (116)      
Beneficial conversion feature of preferred stock 651,562 651,562
Conversion of Series H Preferred Stock into common stock $ 4 (4)
Conversion of Series H Preferred Stock into common stock, shares (50) 40,000      
Exchange of debentures into Series I-2 Preferred Stock 1,331 1,331
Net income (loss) 45,317,921 45,317,921
Balance at Jun. 30, 2018 $ 17,502 $ 318 140,263,291 (270,227,086) (129,945,975)
Balance, shares at Jun. 30, 2018 1,750,225 3,183,349      
Common stock issued in cashless exercise of warrants $ 77 661,304 661,381
Common stock issued in cashless exercise of warrants, shares 768,548      
Conversion of debentures into common stock $ 165 991,413 991,578
Conversion of debentures into common stock, shares 1,649,059      
Stock-based compensation 78,444 78,444
Exchange of debentures into Series I-2 Preferred Stock 89 89
Deemed dividend from trigger of down round provision feature 17,942,578 (17,942,578)
Exchange of note payable and accrued expenses for Series J Preferred Stock $ 2,500 247,500 250,000
Exchange of note payable and accrued expenses for Series J Preferred Stock, shares 250,000      
Common stock issued for conversion of Series I-2 Preferred Stock $ 177 632,924 633,101
Common stock issued for conversion of Series I-2 Preferred Stock, shares 1,764,927      
Adjust treasury shares
Adjust treasury shares, shares (2)      
Net income (loss) 97,196,651 97,196,651
Balance at Sep. 30, 2018 $ 20,002 $ 737 160,817,543 (190,973,013) (30,134,731)
Balance, shares at Sep. 30, 2018 2,000,225 7,365,881      
Balance at Dec. 31, 2018 $ 20,002 $ 12,857 375,845,883 (415,046,606) (39,167,864)
Balance, shares at Dec. 31, 2018 2,000,225 128,567,273      
Common stock issued in cashless exercise of warrants $ 11,961 (11,961)
Common stock issued in cashless exercise of warrants, shares 119,615,384      
Stock-based compensation 8,650 8,650
Conversion of Series I-2 Preferred stock into common stock $ 325,570 318,310 643,880
Conversion of Series I-2 Preferred stock into common stock, shares 3,255,700,000      
Deemed dividend from trigger of down round provision feature 123,861,587 (123,861,587)
Modification of warrants 4,056,425 4,056,425
Net income (loss) (13,441,404) (13,441,404)
Balance at Mar. 31, 2019 $ 20,002 $ 350,388 504,078,894 (552,349,597) (47,900,313)
Balance, shares at Mar. 31, 2019 2,000,225 3,503,882,657      
Balance at Dec. 31, 2018 $ 20,002 $ 12,857 375,845,883 (415,046,606) (39,167,864)
Balance, shares at Dec. 31, 2018 2,000,225 128,567,273      
Common stock issued in cashless exercise of warrants, shares   119,615,384      
Modification of warrants         9,464,991
Net income (loss)         (39,131,999)
Balance at Sep. 30, 2019 $ 20,002 $ 839,894 509,515,347 (578,040,192) (67,664,949)
Balance, shares at Sep. 30, 2019 2,000,225 8,398,936,775      
Balance at Mar. 31, 2019 $ 20,002 $ 350,388 504,078,894 (552,349,597) (47,900,313)
Balance, shares at Mar. 31, 2019 2,000,225 3,503,882,657      
Stock-based compensation 8,650 8,650
Conversion of Series I-2 Preferred stock into common stock $ 250,506 10,587 261,093
Conversion of Series I-2 Preferred stock into common stock, shares 2,505,054,118      
Modification of warrants 5,408,566 5,408,566
Net income (loss) (13,424,827) (13,424,827)
Balance at Jun. 30, 2019 $ 20,002 $ 600,894 509,506,697 (565,774,424) (55,646,831)
Balance, shares at Jun. 30, 2019 2,000,225 6,008,936,775      
Stock-based compensation 8,650 8,650
Conversion of Series I-2 Preferred stock into common stock $ 239,000 239,000
Conversion of Series I-2 Preferred stock into common stock, shares 2,390,000,000      
Net income (loss) (12,265,768) (12,265,768)
Balance at Sep. 30, 2019 $ 20,002 $ 839,894 $ 509,515,347 $ (578,040,192) $ (67,664,949)
Balance, shares at Sep. 30, 2019 2,000,225 8,398,936,775